Home

George Bernard törlés Korszerűsítés median overall survival for diffuse astrocytoma Kiábrándulás ugat Perth Blackborough

Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis |  Anticancer Research
Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis | Anticancer Research

Spotlights on adult patients with pediatric-type diffuse gliomas in  accordance with the 2021 WHO classification of CNS tumors - Frontiers
Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors - Frontiers

IDH1/2 mutation is a prognostic marker for survival and predicts response  to chemotherapy for grade II gliomas concomitantly treated with radiation  therapy
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy

Predicting overall survival in diffuse glioma from the presurgical  connectome | Scientific Reports
Predicting overall survival in diffuse glioma from the presurgical connectome | Scientific Reports

A) Kaplan-Meier plots of 10-year survival by time period for patients... |  Download Scientific Diagram
A) Kaplan-Meier plots of 10-year survival by time period for patients... | Download Scientific Diagram

Astrocytoma progression scoring system based on the WHO 2016 criteria |  Scientific Reports
Astrocytoma progression scoring system based on the WHO 2016 criteria | Scientific Reports

A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in  Patients with Diffuse Gliomas | American Journal of Neuroradiology
A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas | American Journal of Neuroradiology

Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic,  and protoplasmic tumor histology in: Journal of Neurosurgery Volume 119  Issue 2 (2013) Journals
Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology in: Journal of Neurosurgery Volume 119 Issue 2 (2013) Journals

Overall survival among IDH-mutated diffuse gliomas (n = 475) stratified...  | Download Scientific Diagram
Overall survival among IDH-mutated diffuse gliomas (n = 475) stratified... | Download Scientific Diagram

Frontiers Publishing Partnerships | Isocitrate Dehydrogenase IDH1 and IDH2  Mutations in Human Cancer: Prognostic Implications for Gliomas
Frontiers Publishing Partnerships | Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas

Survival patterns of oligoastrocytoma patients: A surveillance,  epidemiology and end results (SEER) based analysis - ScienceDirect
Survival patterns of oligoastrocytoma patients: A surveillance, epidemiology and end results (SEER) based analysis - ScienceDirect

Predicting survival in anaplastic astrocytoma patients in a single-center  cohort of 108 patients | Radiation Oncology | Full Text
Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients | Radiation Oncology | Full Text

Kaplan-Meier overall survival of spinal cord astrocytoma by grade.... |  Download Scientific Diagram
Kaplan-Meier overall survival of spinal cord astrocytoma by grade.... | Download Scientific Diagram

Astrocytoma Tumors – Symptoms, Diagnosis and Treatments
Astrocytoma Tumors – Symptoms, Diagnosis and Treatments

Multidimensional scaling of diffuse gliomas: application to the 2016 World  Health Organization classification system with prognostically relevant  molecular subtype discovery | Acta Neuropathologica Communications | Full  Text
Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery | Acta Neuropathologica Communications | Full Text

Biomedicines | Free Full-Text | The Current State of Adult Glial Tumor  Patients’ Care in Kazakhstan: Challenges in Diagnosis and Patterns in  Survival Outcomes
Biomedicines | Free Full-Text | The Current State of Adult Glial Tumor Patients’ Care in Kazakhstan: Challenges in Diagnosis and Patterns in Survival Outcomes

Current therapeutic approaches to diffuse grade II and III gliomas -  Alberto Picca, Giulia Berzero, Marc Sanson, 2018
Current therapeutic approaches to diffuse grade II and III gliomas - Alberto Picca, Giulia Berzero, Marc Sanson, 2018

Kaplan–Meier survival curves for all lower-grade glioma and WHO 2016... |  Download Scientific Diagram
Kaplan–Meier survival curves for all lower-grade glioma and WHO 2016... | Download Scientific Diagram

Long-term follow-up in adult patients with low-grade glioma (WHO II)  postoperatively irradiated. Analysis of prognostic factors - ScienceDirect
Long-term follow-up in adult patients with low-grade glioma (WHO II) postoperatively irradiated. Analysis of prognostic factors - ScienceDirect

Population-based study on incidence, survival rates, and genetic  alterations of low-grade diffuse astrocytomas and oligodendrogliomas |  SpringerLink
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas | SpringerLink

Current Oncology | Free Full-Text | Diagnostic Approaches to Adult-Type  Diffuse Glial Tumors: Comparative Literature and Clinical Practice Study
Current Oncology | Free Full-Text | Diagnostic Approaches to Adult-Type Diffuse Glial Tumors: Comparative Literature and Clinical Practice Study

Kaplan–Meier survival curves for WHO grade II to III diffuse glioma... |  Download Scientific Diagram
Kaplan–Meier survival curves for WHO grade II to III diffuse glioma... | Download Scientific Diagram

Predicting survival in anaplastic astrocytoma patients in a single-center  cohort of 108 patients | Radiation Oncology | Full Text
Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients | Radiation Oncology | Full Text

A 25-year retrospective, single center analysis of 343 WHO grade II/III  glioma patients: implications for grading and temozolomide therapy |  Journal of Cancer Research and Clinical Oncology
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy | Journal of Cancer Research and Clinical Oncology